Optimizing Chemotherapy for Frail and Elderly Patients with Advanced Gastroesophageal Cancer (aGOAC): the GO2 Phase III Trial

Hall, P, Swinson, D, Lord, S et al. (23 more authors) (2019) Optimizing Chemotherapy for Frail and Elderly Patients with Advanced Gastroesophageal Cancer (aGOAC): the GO2 Phase III Trial. In: 2019 NCRI Cancer Conference of National Cancer Research Institute, 03-05 Nov 2019, Glasgow, Scotland, UK.

Metadata

Authors/Creators:
Dates:
  • Published: 4 October 2019
Institution: The University of Leeds
Funding Information:
FunderGrant number
Cancer Research UKA14923
Cancer Research UKC6003/A3830
Roche Products LtdX120
Cancer Research UKC6003/A10079
Leeds Teaching Hospitals Charitable FoundationFund No IT01
Depositing User: Symplectic Publications
Date Deposited: 20 May 2021 12:22
Last Modified: 20 May 2021 12:22
Status: Published
Identification Number: https://doi.org/10.1038/s41416-019-0555-x
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics